Form4insider filings, from the source

SEC Form 4 · accession 0000899243-17-024006

RHYTHM PHARMACEUTICALS, INC. · RYTM

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Mark J Levin
10% Owner
Kevin P Starr
10% Owner
TRV GP, LLC
10% Owner
Period of report
Oct 10, 2017
Accepted (ET)
Oct 11, 2017 · 4:00 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001649904

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2,F3Oct 10, 2017C3,963,810—A3,981,437D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Series A Convertible Preferred StockF3,F2—Oct 10, 2017C9,479,502D——Common Stock1,033,7510D
Series A-1 Junior Preferred StockF3,F2—Oct 10, 2017C26,868,642D——Common Stock2,930,0590D

Explanation of responses